Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Trial    crawled date : 2021 - 10 - 20    save search

Sight Sciences Announces TearCare® Clinical Data Published in CorneaClinical trial data being used to seek expanded indication from the FDA
Published: 2021-10-20 (Crawled : 22:00) - biospace.com/
SGHT | News | $5.29 -1.67% -1.7% 160K twitter stocktwits trandingview |
| | O: 0.0% H: 3.16% C: 0.35%

fda trial
HistoIndex and Galecto to Collaborate on Galecto's Phase 2a MYLOX-1 Clinical Trial to Advance Myelofibrosis Assessment with AI-based Stain-free Digital Pathology
Published: 2021-10-20 (Crawled : 22:00) - biospace.com/
GLTO | $0.7077 4.94% 4.71% 110K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 3.5% C: 3.5%

phase 2 fibrosis trial phase 2b
The New England Journal of Medicine publishes the results of the NATIVE Phase IIb clinical trial with lanifibranor in NASH
Published: 2021-10-20 (Crawled : 22:00) - globenewswire.com
IVA | $3.28 1.86% 1.83% 12K twitter stocktwits trandingview |
Health Technology
| | O: 3.57% H: 0.0% C: -1.66%

results nash trial
First Industrial Realty Trust Reports Third Quarter 2021 Results
Published: 2021-10-20 (Crawled : 21:00) - prnewswire.com
FR | $46.07 -5.21% 0.0% 2.4M twitter stocktwits trandingview |
Finance
| | O: -1.43% H: 2.57% C: 0.53%

results trial
Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer
Published: 2021-10-20 (Crawled : 21:00) - biospace.com/
RDUS | $18.72 2.74% 2.67% 280K twitter stocktwits trandingview |
Health Technology
| | O: 36.48% H: 9.0% C: -14.74%

positive results cancer topline elacestrant phase 3 breast cancer trial elascestrant
Longeveron Announces Activation of Two New Clinical Sites in ELPIS II Trial of Lomecel-B for Hypoplastic Left Heart Syndrome (HLHS)
Published: 2021-10-20 (Crawled : 21:00) - biospace.com/
LGVN | News P 0 d | $2.005 -4.07% -4.24% 990K twitter stocktwits trandingview |
| | O: -1.31% H: 2.39% C: 0.8%

heart trial syndros lomecel-b
Kymera to Hold Webcast and Conference Call Discussing Data from its KT-474 Phase 1 Trial to Be Presented at the 4th Annual Targeted Protein Degradation Summit on October 27th
Published: 2021-10-20 (Crawled : 20:00) - biospace.com/
KYMR | $35.16 4.15% 3.98% 620K twitter stocktwits trandingview |
Health Technology
| | O: -0.74% H: 0.0% C: -4.19%

phase 1 trial conference
Altra Industrial Motion Corp. Announces Fourth Quarter 2021 Dividend
Published: 2021-10-20 (Crawled : 17:00) - globenewswire.com
AIMC | $61.98 -0.02% 0.0% 0 twitter stocktwits trandingview |
Producer Manufacturing
| | O: -0.14% H: 2.52% C: 1.86%

trial
Industrial Human Capital, Inc. Announces Pricing of $100 Million Initial Public Offering
Published: 2021-10-20 (Crawled : 14:00) - feed.businesswire.com
PIXY 4 | $1.85 -3.65% -3.78% 120K twitter stocktwits trandingview |
Commercial Services
| | O: 1.94% H: 5.71% C: 5.71%

offering trial
Gates Industrial Announces Third-Quarter 2021 Earnings Release Date
Published: 2021-10-20 (Crawled : 13:15) - prnewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M twitter stocktwits trandingview |
Finance
| | O: -0.66% H: 0.83% C: -0.42%
GTES | $17.18 -0.52% 0.0% 1M twitter stocktwits trandingview |
Producer Manufacturing
| | O: 0.24% H: 1.08% C: 0.6%

trial
Clinical Data from Editas Medicine’s Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10 to be Presented at the European Society of Gene and Cell Therapy Annual Congress
Published: 2021-10-20 (Crawled : 13:15) - globenewswire.com
EDIT | $5.56 -0.89% -0.9% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.64% H: 0.71% C: -2.76%

europe ongoing phase 1 therapy trial
CSW Industrials Announces Date for Fiscal 2022 Second Quarter Earnings Release Conference Call
Published: 2021-10-20 (Crawled : 12:15) - globenewswire.com
CSWI | $234.23 0.77% 0.77% 98K twitter stocktwits trandingview |
Process Industries
| | O: 0.3% H: 0.2% C: -0.85%

trials trial conference
Industrial Enzymes Market to Grow by USD 1.94 Billion | Market Size, Trends, Industry Analysis, and Opportunities | 17,000+ Technavio Reports
Published: 2021-10-20 (Crawled : 12:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 2.99% H: 0.01% C: -0.69%

trial
Industrial Energy Efficiency Services Market to Grow by USD 2.53 bn | 17,000+ Technavio Research Reports
Published: 2021-10-20 (Crawled : 12:00) - prnewswire.com
JCI | News | $63.77 0.13% 0.0% 3.2M twitter stocktwits trandingview |
Producer Manufacturing
| | O: 0.25% H: 1.24% C: 0.63%
HON | News M | $191.15 0.42% 0.41% 2M twitter stocktwits trandingview |
Producer Manufacturing
| | O: 0.2% H: 0.66% C: 0.63%

energy research trial
MSC Industrial Supply Co. Reports Fiscal 2021 Fourth Quarter And Full Year Results
Published: 2021-10-20 (Crawled : 11:00) - prnewswire.com
MSM | $91.44 0.37% 0.0% 280K twitter stocktwits trandingview |
Distribution Services
| | O: -0.5% H: 0.49% C: -1.88%

results trial
Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Published: 2021-10-20 (Crawled : 10:00) - biospace.com/
RCKT M | $23.44 -1.01% -1.02% 550K twitter stocktwits trandingview |
Health Technology
| | O: 6.15% H: 1.44% C: -2.95%

treatment europe positive therapy trial
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.